Loading…
Fortrea Holdings Inc. is projected to rise to $17.39 by 2027, a +30% move from its current price of $13.42. FTRE is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $12.97 | $13.42 | $13.88 | -0.01% |
| May 30 | $12.79 | $13.42 | $14.07 | -0.02% |
| May 31 | $12.65 | $13.42 | $14.22 | -0.03% |
| Jun 1 | $12.54 | $13.42 | $14.35 | -0.04% |
| Jun 2 | $12.44 | $13.41 | $14.46 | -0.05% |
| Jun 3 | $12.35 | $13.41 | $14.57 | -0.05% |
| Jun 4 | $12.27 | $13.41 | $14.66 | -0.06% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $12.27 | $13.41 | $14.66 | -0.06% |
| Week 2 | $11.81 | $13.40 | $15.21 | -0.13% |
| Week 3 | $11.48 | $13.39 | $15.63 | -0.19% |
| Week 4 | $11.20 | $13.39 | $16.00 | -0.25% |
| Week 5 | $10.96 | $13.38 | $16.33 | -0.32% |
| Week 6 | $10.74 | $13.37 | $16.64 | -0.38% |
| Week 7 | $10.55 | $13.36 | $16.92 | -0.44% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Fortrea Holdings Inc. is a healthcare company operating as a contract research organization that provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. Its services span clinical pharmacology and clinical development, including activities such as clinical research units, external partnerships, project management, study design and monitoring, bioanalytics and biomarkers, pharmacokinetics, modeling and simulation, and biometrics; and phase I through IV clinical and real-world evidence studies, regulatory affairs, protocol design, operational planning, study and site start-up, patient recruitment, project management, comprehensive site and medical monitoring, data management and biostatistics, pharmacovigilance, medical writing, and mobile clinical services.
The company also provides consulting services comprising product development and regulatory, market access and health economics, and outcomes research, as well as RWE services. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.
Fortrea Holdings Inc. (FTRE) trades in the healthcare space as a contract research organization offering a broad spectrum of pharmacology, development, and consulting services to life sciences customers worldwide. The stock is currently priced at $13.22 with a market capitalization of $1.25B and a rank of 2363.
The 30-day technical picture shows a neutral stance, with RSI14 at 50 and moving averages near-term around $11.14 (SMA50) and $11.77 (SMA200). Key support and resistance sit at $9.38 and $15.64, respectively. The forecast paints a multi-year bullish path, with the 2026 baseline at $13.22 and a trajectory toward higher averages and values through 2050, including a 2050 max of $121.84.
A major floor 48.7% below — a decisive break under it would weaken the trend.
The nearest floor, 28.2% below — buyers have tended to step in here.
The nearest ceiling, 16.5% above — a clean break opens room to run.
A major ceiling 40.9% above — clearing it would confirm fresh momentum.
Key FTRE support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of FTRE market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $13.34 | Buy | $13.40 | Buy |
| MA 10 | $13.64 | Sell | $13.52 | Sell |
| MA 20 | $13.68 | Sell | $13.20 | Buy |
| MA 50 | $11.31 | Buy | $12.29 | Buy |
| MA 100 | $12.45 | Buy | $12.04 | Buy |
| MA 200 | $11.83 | Buy | $11.96 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 56.45 | Neutral |
| Stoch RSI (14) | 9.78 | Buy |
| CCI (20) | -17.30 | Neutral |
| Williams %R (14) | -88.48 | Info |
| MACD (12,26,9) | -0.24 | Sell |
| ROC (12) | -13.03 | Sell |
| Bollinger %B (20,2) | 0.45 | Neutral |
| Stochastic %K (14) | 11.52 | Buy |
| TRIX (15) | 1.12 | Buy |
| Awesome (5,34) | 1.17 | Buy |
| Ultimate (7,14,28) | 35.08 | Neutral |
| Momentum (10) | -1.19 | Sell |
| Aroon Osc (25) | 36.00 | Buy |
| Hull MA (9) | 13.12 | Buy |
| ADX (14) | 24.51 | Buy |
| ATR (14) | 0.32 | Info |
The 30-day picture currently reads NEUTRAL with RSI14 at 50. The near-term moving averages sit at $11.14 for the SMA50 and $11.77 for the SMA200, offering a around-the-round baseline near the current price. Support is noted at $9.38 and resistance at $15.64, framing a recent 30-day range from $10.45 to $16.73.
These levels provide a framework for short-term price action around the current price of $13.22.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $8.87 | $13.42 | $17.15 | 0% | Neutral | |
| $13.48 | $17.39 | $23.95 | +30% | Bullish | |
| $14.91 | $19.91 | $28.62 | +48% | Bullish | |
| $14.15 | $19.45 | $28.91 | +45% | Bullish | |
| $15.53 | $21.92 | $33.50 | +63% | Bullish | |
| $14.69 | $21.23 | $33.26 | +58% | Bullish | |
| $14.01 | $20.70 | $33.16 | +54% | Bullish | |
| $17.13 | $25.85 | $42.23 | +93% | Bullish | |
| $19.02 | $29.29 | $48.74 | +118% | Bullish | |
| $20.38 | $32.00 | $54.16 | +138% | Bullish | |
| $24.82 | $42.60 | $77.40 | +217% | Bullish | |
| $32.72 | $65.84 | $132.51 | +391% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $8.87 | $13.42 | $15.84 | +0.00% |
| June 2026 | $11.64 | $13.75 | $16.66 | +2.43% |
| July 2026 | $11.16 | $13.31 | $16.40 | -3.18% |
| August 2026 | $10.52 | $12.65 | $15.79 | -4.95% |
| September 2026 | $10.64 | $12.88 | $16.24 | +1.81% |
| October 2026 | $10.88 | $13.25 | $16.86 | +2.88% |
| November 2026 | $10.64 | $13.04 | $16.73 | -1.62% |
| December 2026 | $10.77 | $13.27 | $17.15 | +1.77% |
Click any year to see its month-by-month FTRE forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, FTRE could reach as high as $17.15, with a base case around $13.42 and support toward $8.87 — roughly 0% from $13.42. Price action looks broadly range-bound.
Expect FTRE to range from $13.48 to $23.95 through 2027. The $17.39 average target implies a +30% move from current prices. That is up +30% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The FTRE price prediction for 2028 points to an average of $19.91 (low $14.91, high $28.62) — a potential gain of +48% on today's $13.42. Momentum favours further upside here.
In 2029, FTRE is projected to trade between $14.15 and $28.91, averaging $19.45 — a potential gain of +45% from today's $13.42. That is -2% versus the projected 2028 average. Buyers look set to stay in control over this stretch.
Fortrea Holdings Inc.'s 2030 outlook centres on $21.92, within a $15.53 to $33.50 range. That is up +13% on the projected 2029 average. That marks a +63% change versus current levels. Momentum favours further upside here.
By 2031, FTRE could reach as high as $33.26, with a base case around $21.23 and support toward $14.69 — roughly +58% from $13.42. Buyers look set to stay in control over this stretch.
Expect FTRE to range from $14.01 to $33.16 through 2032. The $20.70 average target implies a +54% move from current prices. That is -2% versus the projected 2031 average. Momentum favours further upside here.
The FTRE price prediction for 2033 points to an average of $25.85 (low $17.13, high $42.23) — a potential gain of +93% on today's $13.42. Buyers look set to stay in control over this stretch.
In 2034, FTRE is projected to trade between $19.02 and $48.74, averaging $29.29 — a potential gain of +118% from today's $13.42. That is up +13% on the projected 2033 average. Momentum favours further upside here.
Fortrea Holdings Inc.'s 2035 outlook centres on $32.00, within a $20.38 to $54.16 range. That is up +9% on the projected 2034 average. That marks a +138% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, FTRE could reach as high as $77.40, with a base case around $42.60 and support toward $24.82 — roughly +217% from $13.42. Momentum favours further upside here.
Expect FTRE to range from $32.72 to $132.51 through 2050. The $65.84 average target implies a +391% move from current prices. That is up +55% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in FTRE today (≈ 74.515648 FTRE) could be worth
$4,905.96
+$3,905.96 (+391%) by 2050 · US Dollar
Based on the average projected FTRE price of $65.84 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in FTREwould be worth at today's price.
$1,000 invested in FTRE on May 27, 2025 (≈ 240.96385 FTRE) would be worth
$3,233.73
+$2,233.73 (+223.4%) today · 3.23× · US Dollar
Based on a FTRE entry price of $4.15 vs. today's $13.42.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $13.7 | $979.56 | -2.0% |
| 1 month ago | $10.6 | $1,266.04 | +26.6% |
| 3 months ago | $10.8 | $1,242.59 | +24.3% |
| 6 months ago | $12.71 | $1,055.86 | +5.6% |
| 1 year ago | $4.15 | $3,233.73 | +223.4% |
| All time (2.9y) ago | $30.1 | $445.85 | -55.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our FTRE forecast.
Our base-case forecast reaches $27.00 around 2034.
Implied market cap at $27.00: $2.55B
The multi-year forecast shows a bullish trajectory from 2027 onward, with the average price climbing from $16.78 (2027) to higher levels through 2050. Notable milestones include 2030 with an average of $20.94 and a max of $32.47 (ROI 58.4, sentiment BULLISH), 2033 with an average of $23.85 and a max of $39.65 (ROI 80.4), and 2040 with an average of $38.11 and a max of $70.72 (ROI 188.3). By 2050, the forecast envisions an average of $59.06 and a max of $121.84 (ROI 346.8, sentiment BULLISH).
Across the horizon, the outlook shifts toward higher price levels and elevated ROI, reflecting a persistent bullish stance, while underscoring that these are estimates and not guarantees. Higher potential outcomes exist, but risk and uncertainty remain inherent in forward-looking projections.
Tap a question to reveal the answer.
In 2030 the forecast shows a min of $14.64, an average of $20.94, and a max of $32.47, with an ROI of 58.4 and a BULLISH sentiment.
The forecast shows a bullish path from 2027 onward, with 2027 avg $16.78 (ROI 26.9), 2028 avg $19.10 (ROI 44.5), 2029 avg $18.71 (ROI 41.5), 2030 avg $20.94 (ROI 58.4), and 2050 avg $59.06 (ROI 346.8). The 2026 baseline is neutral with an avg of $13.22 and ROI 0.
Yes. The forecast maximum by 2050 is $121.84, indicating a path above the $100 level in the projection window, though these are not guarantees.
Current price is $13.22 and market cap is $1.25B.
The 30-day range is $10.45 to $16.73. RSI0 is 50.00, with SMA50 at $11.14 and SMA200 at $11.77. The near-term support is $9.38 and resistance is $15.64.
Fortrea Holdings Inc. Community Discussion
0Share your Fortrea Holdings Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.